BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30522422)

  • 1. [Relation of cervical cancer with the results of human papillomavirus (HPV) screening carried out via hybrid capture 2 method on 52.000 women in Erzurum].
    Göktuğ Kadıoğlu B; Çınar Tanrıverdi E; Alay H; Uçar M
    Mikrobiyol Bul; 2018 Oct; 52(4):367-375. PubMed ID: 30522422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigation of human papillomavirus prevalence in women in Eskişehir, Turkey by Pap smear, hybrid capture 2 test and consensus real-time polymerase chain reaction and typing with pyrosequencing method].
    Aslan FG; Us T; Kaşifoğlu N; Özalp SS; Akgün Y; Öge T
    Mikrobiyol Bul; 2016 Jan; 50(1):73-85. PubMed ID: 27058331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation.
    Othman N; Othman NH
    Asian Pac J Cancer Prev; 2014; 15(5):2245-9. PubMed ID: 24716964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevelance of human papillomavirus (HPV) genotypes detected by PCR in women with normal and abnormal cervico-vaginal cytology.
    Beyazit F; Sılan F; Gencer M; Aydin B; Paksoy B; Unsal MA; Ozdemir O
    Ginekol Pol; 2018; 89(2):62-67. PubMed ID: 29512809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial results of population based cervical cancer screening program using HPV testing in one million Turkish women.
    Gultekin M; Zayifoglu Karaca M; Kucukyildiz I; Dundar S; Boztas G; Semra Turan H; Hacikamiloglu E; Murtuza K; Keskinkilic B; Sencan I
    Int J Cancer; 2018 May; 142(9):1952-1958. PubMed ID: 29235108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results from a cervical cancer screening program in Samsun, Turkey.
    Arslan HN; Oruc MA
    BMC Womens Health; 2022 Aug; 22(1):331. PubMed ID: 35927723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
    Mayrand MH; Duarte-Franco E; Coutlée F; Rodrigues I; Walter SD; Ratnam S; Franco EL;
    Int J Cancer; 2006 Aug; 119(3):615-23. PubMed ID: 16572425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of human papillomavirus infection among women from quilombo communities in northeastern Brazil.
    Nascimento MDDSB; Vidal FCB; Silva MACND; Batista JE; Lacerda Barbosa MDC; Muniz Filho WE; Bezerra GFB; Castro Viana GM; Branco RCC; Brito LMO
    BMC Womens Health; 2018 Jan; 18(1):1. PubMed ID: 29291721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
    Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can self vaginal douching for high risk HPV screening replace or assist efficacy of cervical cancer screening?
    Suwannarurk K; Bhamarapravatana K; Kheolamai P; Thaweekul Y; Mairaing K; Poomtavorn Y; Pattaraarchachai J
    Asian Pac J Cancer Prev; 2010; 11(5):1397-401. PubMed ID: 21198300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of single-, double- and triple-combined testing, including Pap test, HPV DNA test and cervicography, as screening methods for the detection of uterine cervical cancer.
    Kim JH; Kim IW; Kim YW; Park DC; Kim YW; Lee KH; Ahn TG; Han SJ; Ahn WS
    Oncol Rep; 2013 Apr; 29(4):1645-51. PubMed ID: 23443346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
    Melinte-Popescu A; Costăchescu G
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):536-9. PubMed ID: 23077949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
    Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
    Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
    Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
    Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
    Cibas ES; Hong X; Crum CP; Feldman S
    Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
    Učakar V; Poljak M; Oštrbenk A; Klavs I
    J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Study of Cytology and Histopathology of Cervical Lesion in VIA Positive Patients and Its Correlation with High Risk Human Papilloma Virus.
    Ansari NP; Saleh FM; Shahida SM; Rahman EN
    Mymensingh Med J; 2017 Jul; 26(3):505-513. PubMed ID: 28919602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Srisomboon J; Intaraphet S; Siriaunkgul S
    PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.